Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 3, 1997, Pages 397-405

  Hirata, Yukiya ^a   Aisaka, Kazuo ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Conscious dog; Coronary blood flow; JTV 506; Potassium channel opener; Vasodilator

Indexed keywords

4 [(1,6 DIHYDRO 1 METHYL 6 OXO 3 PYRIDAZINYL)AMINO] 3 HYDROXY 2,2 BIS(METHOXYMETHYL)CHROMAN 6 CARBONITRILE; DILTIAZEM; GLYCERYL TRINITRATE; LEMAKALIM; NICORANDIL; NIFEDIPINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART RATE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VASODILATATION;

ADMINISTRATION, ORAL; ANIMALS; BENZOPYRANS; BLOOD PRESSURE; CHROMANS; CORONARY CIRCULATION; CROMAKALIM; DILTIAZEM; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; INJECTIONS, INTRAVENOUS; MALE; NIACINAMIDE; NICORANDIL; NITROGLYCERIN; PYRROLES; VASODILATOR AGENTS;

EID: 0030956684     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199703000-00014     Document Type: Article

References (28)

1. Cho H, Kato S, Sayama S, et al. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers. J Med Chem 1996;39:3797-805.
2. + channels. Trends Pharmacol Sci 1989;10:431-5.
3. Longman SD, Hamilton TC. Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential. Med Res Rev 1992;12:73-148.
4. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 1993;33: 597-637.
5. Buckingham RE, Clapham JC, Hamilton TC, Longman SD, Norton J, Poyser RH. BRL-34915, a novel antihypertensive agent: comparison of effects on blood pressure and other hemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol 1986;8:798-804.
6. Longman SD, Clapham JC, Wilson C, Hamilton TC. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil. J Cardiovasc Pharmacol 1988;12:535-42.
7. Hof RP, Quast U, Cook NS, Blarer S. Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers. Circ Res 1988;62: 679-86.
8. Clapham JC, Hamilton TC, Longman SD, Buckingham RE, Campbell CA, Ilsley GL. Antihypertensive and haemodynamic properties of potassium channel activating (-) enantiomer of cromakalim in animal models. Arzneimittelforschung 1991;41: 385-91.
9. Buckingham RE, Hamilton TC, Howlett S, Mootoo S, Wilson C. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol 1989;97:57-64.
10. Cavero I, Mondot S, Mestre M. The vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther 1989;248:1261-8.
11. Winquist RJ, Heaney LA, Wallace AA, et al. Glyburide blocks the relaxation response to BRL34915 (cromakalim), minoxidil sulphate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther 1989;248:149-56.
12. Fox JS, Whitehead M, Shanks RG. Cardiovascular effects of cromakalim (BRL34915) in healthy volunteers. Br J Clin Pharmacol 1991;32:45-9.
13. Lebel M, Grose JH, Lacourciere Y. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension. Am J Hypertens 1991;4:740-4.
14. Vatner SF, Braunwald E. Cardiovascular control mechanisms in the conscious state. N Engl J Med 1975;293:970-6.
15. Cox RH, Bagshaw RJ. Influence of anesthesia on the response to carotid hypotension in dogs. Am J Physiol 1979;237:H424-32.
16. Kawashima S, Liang CS. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine. J Pharmacol Exp Ther 1985;232:369-75.
17. Giudicelli JF, Rochelle CD, Berdeaux A. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs. J Pharmacol Exp Ther 1990;255:836-42.
18. ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine. J Pharmacol Exp Ther 1993;265:1026-37.
19. Damiano BP, Giardino EC, Haertlein BJ, Stump GL, Mitchell JA, Falotico R. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs. J Cardiovasc Pharmacol 1994;23:300-10.
20. + channel opener, in anesthetized and conscious dogs. Eur J Pharmacol 1994;264:285-93.
21. Kusumoto K, Awane Y, Kitayoshi T, et al. Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs. J Cardiovasc Pharmacol 1994; 24:929-36.
22. Atwal KS, Grover GJ, Ferrara FN, et al. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopynanylcyanoguanidines: modification of the benzopyran ring. J Med Chem 1995;38:1966-73.
23. + channels? Trends Pharmacol Sci 1993;14:332-7.
24. VandenBurg MJ, Woodward SR, Hossain M, Stewart-Long P, Tasker TCG. Potassium channel activators lower blood pressure: an initial study of BRL34915 in hypertensive patients. J Hypertens 1986:4 (suppl 6):S166-7.
25. Eckl KM, Greb WH. Potassium channel activation in the vascular smooth muscle cell membrane - a new mechanism of action in antihypertensive treatment - early clinical results with BRL34915. Clin Exp Hypertens 1987;(A)9:160.
26. Nayler WG. Calcium antagonists and angina. In: Nayler WG, ed. Calcium antagonists. New York: Academic Press, 1988:177-92.
27. Krumenacker M, Roland E. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol 1992;20(suppl 3):S93-102.
28. Kinoshita M, Hashimoto K, Ohbayashi Y, Inoue T, Taguchi H, Mitsunami K. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism. Am J Cardiol 1989;63:71-4J.